You are here

Clinical Trials: Neuromuscular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, July 23, 2021 - 12:00
Condition:   Inclusion Body Myositis
Intervention:   Device: Adipose Derived Regenerative Cells
Sponsor:   University of Kansas Medical Center
Not yet recruiting
Posted: Tuesday, June 8, 2021 - 12:00
Conditions:   Systemic Sclerosis;   Inflammatory Myopathies
Intervention:   Other: Collection of biological samples
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting
Posted: Monday, April 19, 2021 - 12:00
Condition:   ALS (Amyotrophic Lateral Sclerosis)
Interventions:   Drug: MNC (Mononuclear cells);   Drug: Placebo / Saline
Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Not yet recruiting
Posted: Tuesday, February 9, 2021 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Biological: Lenzumestrocel;   Drug: Riluzole
Sponsor:   Corestem, Inc.
Posted: Monday, January 25, 2021 - 12:00
Conditions:   Polymyositis;   Dermatomyositis
Sponsor:   University of Florida
Not yet recruiting
Posted: Friday, December 4, 2020 - 12:00
Condition:   Brachial Plexus Neuropathies
Interventions:   Procedure: Nerve transfer procedure;   Procedure: Nerve transfer with HAM-AdMSC composite wrapping
Sponsor:   Dr. Soetomo General Hospital
Posted: Thursday, December 3, 2020 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: Mesenchymal stem cells isolated from Wharton's jelly
Sponsors:   Polski Bank Komorek Macierzystych JSC (PBKM);   The National Centre for Research and Development
Posted: Friday, July 24, 2020 - 12:00
Conditions:   Myositis;   Dermatomyositis;   Polymyositis;   Immune-Mediated Necrotizing Myopathy
Intervention:   Other: High-intensity strength training
Sponsors:   Rigshospitalet, Denmark;   University of Southern Denmark;   Odense University Hospital
Not yet recruiting
Posted: Tuesday, March 10, 2020 - 12:00
Condition:   Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Interventions:   Drug: Memantine Hydrochloride Oral Solution;   Drug: Trazodone Hydrochloride oral solution;   Drug: Placebo oral solution
Sponsors:   University of Edinburgh;   University College, London;   University of Warwick;   NHS Lothian
Posted: Tuesday, January 7, 2020 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: RAPA-501 Autologous T cells
Sponsors:   Rapa Therapeutics LLC;   Massachusetts General Hospital;   Hackensack Meridian Health
Not yet recruiting